SL Pharma Delegation Gains Global Exposure at CPHI Worldwide 2026 📈

The Sri Lanka Export Development Board (EDB), alongside Sri Lankan foreign missions in Italy, facilitated an exposure visit and B2B networking for a five-member local business delegation at the 37th edition of CPHI Worldwide 2026 in Milan (Oct 6–8). • Delegation & Sectors Five participating local companies represented key growth sub-sectors including pharmaceuticals, veterinary, cosmeceuticals, and natural products: • State Pharmaceutical Manufacturing Corporation • Siddhalepa Exports (Pvt) Ltd • Lina Manufacturing (Pvt) Ltd • Vetpharma Biotechnology (Pvt) Ltd • Aithra Pharmaceuticals (Pvt) Ltd • Key Objective & Economic Context The initiative aims to drive export diversification and move toward higher-value production by connecting Sri Lankan manufacturers with global supply chains, CDMOs, and API suppliers. Local producers engaged with global stakeholders across Ireland, Italy, the UK, France, Spain, Barbados, and Tanzania to address strict international regulatory hurdles (such as EU-GMP standards) and tap into new export markets.